Natraj Proteins Limited has announced its financial results for the third quarter and nine months ended 31st December, 2025, showcasing a remarkable turnaround in profitability despite facing revenue headwinds. The agri-business company demonstrated strong operational efficiency improvements during the quarter.

Financial Performance Highlights

The company's quarterly performance showed significant improvement across key profitability metrics:

The company achieved a profit before tax of ₹290.13 lakhs in Q3FY26, compared to ₹5.15 lakhs in the corresponding quarter of the previous year, marking an exceptional improvement in operational performance.

Nine-Month Performance Analysis

For the nine-month period ended 31st December, 2025, Natraj Proteins demonstrated a complete turnaround from losses to profitability:

Cost Management and Operational Efficiency

The company's improved profitability was driven by effective cost management strategies. Cost of materials consumed decreased to ₹2094.36 lakhs in Q3FY26 from ₹2747.38 lakhs in Q3FY25. Total expenses for the quarter were ₹2591.2 lakhs compared to ₹3337.66 lakhs in the previous year, reflecting disciplined cost control measures.

Other income remained modest at ₹4.37 lakhs for the quarter, while finance costs increased to ₹59.36 lakhs from ₹50.11 lakhs year-on-year. Employee benefits expense decreased to ₹23.71 lakhs from ₹32.74 lakhs in the corresponding quarter.

Corporate Governance and Compliance

The Board of Directors meeting was held on 13th February, 2026, where the unaudited financial results were considered and approved. The results were also reviewed by the Audit Committee and received a limited review report from statutory auditors M/s Bhutoria Ganesan & Co. The company maintains a paid-up share capital of ₹374.7 lakhs with face value of ₹10 per share.

The financial results were prepared in compliance with Indian Accounting Standards (Ind AS) as notified under Section 133 of the Companies Act, 2013, ensuring adherence to regulatory requirements and transparency in financial reporting.

Natraj Proteins Limited , a company operating in the solvent extraction and commodities derivative trading segments, has reported a substantial loss for the second quarter of the fiscal year 2026. The company's financial performance shows a marked deterioration compared to the same period last year.

Financial Highlights

Natraj Proteins Limited experienced a significant downturn in its financial performance for the quarter ended September 30, 2025. The company reported a net loss of ₹286.46 crore, a stark contrast to the profit of ₹101.48 crore recorded in the same quarter of the previous year. This represents a substantial decline of 382.28% in the company's bottom line.

Revenue and Operational Performance

The company's revenue from operations saw a marginal decrease of 1.35%, falling to ₹2655.74 crore from ₹2692.17 crore in the corresponding quarter of the previous year. This slight decline in revenue, coupled with increased expenses, contributed to the significant loss reported by the company.

Earnings Per Share

The earnings per share (EPS) for the quarter plummeted to negative ₹7.65, down from a positive ₹2.71 in the same quarter of the previous year. This sharp decline in EPS reflects the substantial impact of the loss on shareholder value.

Segment Performance

Natraj Proteins operates in two primary segments: solvent extraction and commodities derivative trading. However, the company's financial report does not provide a detailed breakdown of segment-wise performance, as the sales from commodities derivatives were below the threshold limits for segmental reporting.

Conclusion

The dramatic shift from profit to loss in just one year raises questions about the factors contributing to this decline. As Natraj Proteins navigates through this difficult period, stakeholders will likely keep a close watch on the company's future financial reports and any strategic initiatives announced to improve its financial health and operational performance.